Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Interventional Clinical Study of Treatment With Upadacitinib Extended-Release Tablets Among Patients Suffering From Refractory Uveitis

NCT07773623 is registered in ClinicalTrials.gov with Tianjin Medical University as lead sponsor.

NCT NCT07773623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07773623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Interventional Clinical Study of Treatment With Upadacitinib Extended-Release Tablets Among Patients Suffering From Refractory Uveitis
Lead sponsor
Tianjin Medical University
Phase
Phase 4
Overall status
Active, not recruiting
Start date
January 1, 2025
Completion date
December 31, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

uveitis